Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of June 2025, specifically reporting on a transaction dated June 2, 2025. The filing serves as a notification of a transaction by a Person Discharging Managerial Responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a disclosure of a share transaction.
| Metric | Value |
|---|---|
| Transaction Type | Purchase of Ordinary Shares |
| Volume | 3,567 shares |
| Price per Share | £3.5085 |
| Total Transaction Value | £12,514.82 |
| Exchange | London Stock Exchange (XLON) |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely discloses an increase in shareholding by a Non-Executive Director.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory compliance notification regarding insider trading activity.
Key Facts for Investor Verification
- Insider Confidence: Sally Johnson, a Non-Executive Director, purchased 3,567 shares on June 2, 2025, indicating personal investment in the company at a price of £3.5085.
- Regulatory Compliance: The transaction was executed on the London Stock Exchange and reported to the SEC via Form 6-K to satisfy UK Market Abuse Regulation requirements.
- Scope Limitation: This filing does not provide any operational or financial results for the period; investors should refer to the company's Form 20-F or interim reports for financial performance.